Skip to main content
Fig. 6 | Journal of Experimental & Clinical Cancer Research

Fig. 6

From: The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer

Fig. 6

A 65-genes ALK signature is predictive of survival only in CMS1 colon cancer subtype. Bioinformatic study performed on the same dataset of patients employed for the analysis reported in Fig. 1. Subjects were stratified on the basis of CMS classification and high (red line) or low (black line) expression of a signature of 65 ALK-related genes. Data were filtered according to the Hochberg (step-up) multiple testing correction

Back to article page